BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 268125)

  • 21. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial dysplasia of the cervix uteri. The population screening for cervical carcinoma in the County of Maribo, 1967-69.
    Berget A
    Dan Med Bull; 1974 Aug; 21(5):169-71. PubMed ID: 4851895
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
    Takahashi K; Moriyama M; Takamiya O; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
    La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
    Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of cancer of the cervix uteri].
    Walton RJ; Blanchet M; Boyes DA; Carmichael J; Marshall KG; Miller AB; Thompson DW
    Union Med Can; 1976 Jul; 105(7):997-1047. PubMed ID: 960289
    [No Abstract]   [Full Text] [Related]  

  • 26. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
    Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico.
    Martínez I
    Bol Asoc Med P R; 1984 Mar; 76(3):100-6. PubMed ID: 6586182
    [No Abstract]   [Full Text] [Related]  

  • 29. [Population screening for cervix carcinoma in the city of Rotterdam, 1st round].
    van der Lee-Bijlsma A
    Ned Tijdschr Geneeskd; 1981 Dec; 125(49):2012-5. PubMed ID: 7322220
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
    Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
    Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
    Klinkhamer PJ; van der Graaf Y; Vooijs GP
    Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of cervical screening - expectation and reality].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2000; 39(3):23-4. PubMed ID: 11187989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
    Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
    Korn AP; Judson PL; Zaloudek CJ
    J Reprod Med; 1998 Sep; 43(9):774-8. PubMed ID: 9777615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increase of in-situ cervix uteri carcinoma in women under 35; data analysis from family practice 1974-1986].
    Boon ME; Rietveld WJ; de Graaff Guilloud JC
    Ned Tijdschr Geneeskd; 1988 Jul; 132(27):1240-3. PubMed ID: 2840584
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix.
    Syrjänen KJ; Heinonen UM; Kauraniemi T
    Acta Cytol; 1981; 25(1):17-22. PubMed ID: 6937062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The costs of cancer screening (author's transl)].
    Neumann G
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):615-8. PubMed ID: 1175903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplasia and carcinoma in situ of the uterine cervix: prevalence in very young women (under age 22). A one-year study in a health plan population.
    Snyder RN; Ortiz Y; Willie S; Cove JK
    Am J Obstet Gynecol; 1976 Apr; 124(7):751-6. PubMed ID: 1258935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness and ultilization of screening cytology for cervical cancer in the Federal Republic of Germany (author's transl)].
    Schwartz FW
    Geburtshilfe Frauenheilkd; 1981 Apr; 41(4):259-62. PubMed ID: 6908873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cancer of the uterine cervix in Greenland.
    Nielsen NH; Jensen H
    APMIS; 1993 Apr; 101(4):290-4. PubMed ID: 8323738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.